Relief Therapeutics (OTCMKTS:RLFTF) Shares Down 1.8% – What’s Next?

Relief Therapeutics Holding SA (OTCMKTS:RLFTFGet Free Report)’s share price traded down 1.8% during trading on Wednesday . The company traded as low as $2.62 and last traded at $2.74. 931 shares traded hands during trading, a decline of 71% from the average session volume of 3,190 shares. The stock had previously closed at $2.79.

Relief Therapeutics Trading Down 1.8%

The business has a fifty day moving average of $2.84 and a 200 day moving average of $3.22.

Relief Therapeutics Company Profile

(Get Free Report)

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.

Read More

Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.